Five years on, many Australians and Americans still treat the COVID response as a closed chapter of over-caution and noble mistakes. Steve Deace refuses that framing. In conversation with Seth Gruber he contends that Anthony Fauci and allied agencies understood the limits and risks of the mRNA products long before mandates rolled out, and that the virus’s origin is tied to research that deliberately tested how bat coronaviruses could jump to humans.

The episode matters now because legal and political pressure for scrutiny has not disappeared. Deace points to state-level interest in Florida, congressional referrals, and the simple fact that no comprehensive public reckoning has occurred. For readers who want to test the strongest version of the “they knew” argument against the public record, this is a concentrated presentation of that case.

Steve Deace’s central claim is straightforward: the COVID response was never primarily about public health once the data on transmission and adverse events became clear. He walks Gruber through a sequence that begins well before 2020.

In the 2010s, he says, scientists sought to create preemptive vaccines against SARS- and MERS-like threats. One method involved gain-of-function work aimed specifically at “spillover potential”—identifying what would allow novel coronaviruses, not yet pathogenic in humans, to become so. Deace compares ordinary gain-of-function to testing an atomic bomb; the spillover version, he argues, is closer to placing people inside the blast radius to observe the effects. He notes that such research was paused under Obama after scientists warned it was too dangerous, then resumed around 2017 during the Trump transition, with grants flowing to the Wuhan Institute of Virology among other sites. The viruses, he stresses, were collected from remote bat habitats and brought into a densely populated urban centre.

Deace links the timing to Chinese domestic pressures—trade conflict, Hong Kong unrest, and the World Military Games held in Wuhan in late 2019. He does not claim definitive proof of intentional release, but argues the combination of high-risk research and geopolitical strain is hard to ignore. He further contends that Fauci’s early 2020 comments were comparatively measured until it became apparent that U.S.-funded work was implicated; the subsequent hard turn toward lockdowns and suppression of natural-immunity discussion, in Deace’s view, reflected both panic and the discovery of political utility.

On the vaccines themselves, Deace is blunt. Moderna, he notes, had never brought a successful product to market before Operation Warp Speed. Traditional vaccine development for respiratory viruses had repeatedly failed safety and efficacy hurdles; mRNA was presented as a shortcut. He cites CDC director Rochelle Walensky’s August 2021 admission on CNN that the vaccines no longer prevented infection or transmission, followed weeks later by Biden’s workplace mandate. That sequence, Deace says, means people were required to accept 100 percent of the liability for a product already known to offer negative efficacy against spread.

He points to the CDC’s own v-safe data showing an 8 percent serious adverse-event rate among participants, and to internal texts acknowledging elevated miscarriage signals after second doses. Gruber adds the fetal-tissue dimension, citing researchers who argue humanised mice using abortion-derived material were necessary for the cross-species work. Deace estimates excess deaths and reproductive harms in the high hundreds of thousands to millions in the United States alone when lockdowns, delayed care and mental-health effects are included—figures that remain contested and require independent verification.

Motives, in Deace’s telling, were plural: a global compliance test, a purge of non-compliant military personnel (especially those of strong religious conviction), economic opportunity for pharma, and the chance to hobble Trump’s final year. He is careful to say human beings are not algorithms; multiple interests converged. The absence of any formal mea culpa once Omicron arrived and public compliance collapsed is, for him, evidence that the policy was never provisional.

The conversation is strongest when it sticks to documented admissions and grant paper trails. It is weaker when it moves into speculative geopolitical causation or precise body counts without citing primary studies in real time. Listeners should treat medical and statistical claims as assertions requiring their own checking against original CDC, NIH and journal sources. The episode does not pretend to be a neutral history; it is an advocacy case for accountability. For readers already sceptical of the official narrative, it supplies a coherent timeline. For those still inclined to give officials the benefit of the doubt, it forces the question of why certain data points were publicly minimised while mandates continued.